Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: DOXIL|DRUG: Abraxane
Sponsor: West Virginia University
Collaborators: Ortho Biotech, Inc.